Non Small Cell Lung Cancer Trial of Durvalumab and Tremelimumab in Advanced Epidermal Growth Factor Receptor (EGFR) Mutant Disease.
Clinical trial NCT03994393 · UNKNOWN
Trial details
- NCT number
- NCT03994393
- Sponsor
- University of Sydney
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-23
- Primary completion
- 2023-06-30
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.